• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[细胞毒性药物治疗的髓母细胞白血病患者血液淋巴细胞及其亚群的变化]

[Changes in blood lymphocytes and their subpopulation in patients with myeloblastic leukemia treated with cytostatic agents].

作者信息

Urasiński I, Proniewska M, Schumacher K

出版信息

Acta Haematol Pol. 1979 Apr-Jun;10(2):129-36.

PMID:314215
Abstract

Quantitative determinations of lymphocytas were done in the active period of the disease, immediately after treatment by the COAP schedule and during remission. In 6 patients the determinations were done several times during 20 weeks of maintenance treatment. It was found that independently of the stage of the disease the absolute lymphocyte count and the counts of B and T populations were low, while that of lymphocyte O population was raised. It was observed that the reduced count concerned all 4 subclasses of lymphocytes B, that is those with surface receptors for IgA, IgM, IgG and IgE immunoglobulins. In remission the values of lymphocytes and their T and B subpopulations increased, failing, however, to reach the normal values. This rise was more pronounced in the case of lymphocytes T. Lymphocyte depression in these patients is explained by the authors as due mainly to intensive cytostatic treatment.

摘要

在疾病活动期、采用COAP方案治疗后立即以及缓解期进行了淋巴细胞的定量测定。6例患者在维持治疗的20周内进行了多次测定。结果发现,无论疾病处于何种阶段,淋巴细胞绝对计数以及B和T细胞群计数均较低,而O淋巴细胞群计数升高。观察到淋巴细胞B的所有4个亚类计数均降低,即具有IgA、IgM、IgG和IgE免疫球蛋白表面受体的亚类。缓解期淋巴细胞及其T和B亚群的值有所增加,但未达到正常值。T淋巴细胞的这种升高更为明显。作者认为这些患者的淋巴细胞减少主要是由于强化的细胞抑制治疗所致。

相似文献

1
[Changes in blood lymphocytes and their subpopulation in patients with myeloblastic leukemia treated with cytostatic agents].[细胞毒性药物治疗的髓母细胞白血病患者血液淋巴细胞及其亚群的变化]
Acta Haematol Pol. 1979 Apr-Jun;10(2):129-36.
2
[Lymphocyte subpopulations in non-Hodgkin's lymphoma during cytostatic therapy].[细胞抑制疗法期间非霍奇金淋巴瘤中的淋巴细胞亚群]
Z Gesamte Inn Med. 1979 Dec 1;34(23):704-8.
3
[Immunological characteristics of lymphocytes during intensive treatment maintaining remission of acute lymphoblastic leukemia in children and following withdrawal from chemotherapy].[儿童急性淋巴细胞白血病强化治疗维持缓解期及化疗停药后淋巴细胞的免疫特性]
Acta Haematol Pol. 1979 Apr-Jun;10(2):99-106.
4
[Evaluation of lymphocyte subpopulations during the remission-maintaining treatment of patients with myeloblastic leukemia].[急性髓细胞白血病患者缓解维持治疗期间淋巴细胞亚群的评估]
Acta Haematol Pol. 1987 Jan-Jun;18(1-2):28-34.
5
[T and B lymphocytes before, during, and after cytostatic therapy of acute lymphoblastic leukemia (ALL) in children (author's transl)].儿童急性淋巴细胞白血病(ALL)细胞抑制治疗前、治疗期间及治疗后的T和B淋巴细胞(作者译)
Klin Padiatr. 1977 May;189(3):234-41.
6
Influence of prednisone and cytostatics on human blood B-, T- and O-lymphocytes in diseases.
Scand J Haematol. 1975 Sep;15(2):109-16.
7
Deficiency of antibody-dependent cellular cytotoxicity and mitogen-induced cellular cytotoxicity effector cell function in patients with acute myelogenous leukemia in remission.急性髓性白血病缓解期患者抗体依赖性细胞毒性和丝裂原诱导的细胞毒性效应细胞功能缺陷。
Cancer Res. 1979 Sep;39(9):3357-62.
8
Studies on the immune status of children with acute lymphocytic leukaemia. II. In remission with and without cytostatic treatment.急性淋巴细胞白血病患儿免疫状态的研究。II. 接受和未接受细胞抑制治疗的缓解期患儿。
Clin Exp Immunol. 1976 Dec;26(3):414-8.
9
Quantitative study of T and B lymphocytes in Hodgkin's disease.霍奇金病中T淋巴细胞和B淋巴细胞的定量研究。
Biomedicine. 1977 Apr;26(2):137-44.
10
[Qualitative and quantitative behavior of B-lymphocytes and immunoglobulins in the serum of children with acute leukemia after a single immunoglobulin concentrate substitution].
Folia Haematol Int Mag Klin Morphol Blutforsch. 1981;108(3):392-9.